Home/Filings/4/0001062993-24-005212
4//SEC Filing

Smith Thomas B 4

Accession 0001062993-24-005212

CIK 0001267565other

Filed

Mar 3, 7:00 PM ET

Accepted

Mar 4, 4:26 PM ET

Size

4.6 KB

Accession

0001062993-24-005212

Insider Transaction Report

Form 4
Period: 2024-02-29
Smith Thomas B
EVP and Chief Medical Officer
Transactions
  • Sale

    Common Stock

    2024-02-29$36.76/sh995$36,58063,409 total

Issuer

COLLEGIUM PHARMACEUTICAL, INC

CIK 0001267565

Entity typeother

Related Parties

1
  • filerCIK 0001748462

Filing Metadata

Form type
4
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 4:26 PM ET
Size
4.6 KB